Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Linhe WANG"'
Autor:
Bao Dai, Lei Xu, Shikuo Rong, Muye Song, Ziteng Lan, Weijian Chen, Lingyun Zhang, Yongchen Liu, Linhe Wang, Jinghua Li, Jian Chen, Zeyu Wu
Publikováno v:
Biology Direct, Vol 19, Iss 1, Pp 1-16 (2024)
Abstract Background RNA methylation, an important reversible post-transcriptional modification in eukaryotes, has emerged as a prevalent epigenetic alteration. However, the role of the m6A reader YTH domain family 2 (YTHDF2) has not been reported in
Externí odkaz:
https://doaj.org/article/9fd8f98c366d462499e0385039657d51
Autor:
Shikuo Rong, Bao Dai, Chunrong Yang, Ziteng Lan, Linhe Wang, Lei Xu, Weijian Chen, Jian Chen, Zeyu Wu
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-18 (2024)
Abstract The heterogeneous nuclear ribonucleoprotein C (HNRNPC) plays a crucial role in tumorigenesis, yet its role in papillary thyroid carcinoma (PTC) remains elusive. Herein, we elucidated the function and molecular mechanism of HNRNPC in PTC tumo
Externí odkaz:
https://doaj.org/article/e79ddec6f1574984b4ab668292f5d69d
Autor:
Zhiyong Guo, Meixian Yin, Chengjun Sun, Guixing Xu, Tielong Wang, Zehua Jia, Zhiheng Zhang, Caihui Zhu, Donghua Zheng, Linhe Wang, Shanzhou Huang, Di Liu, Yixi Zhang, Rongxing Xie, Ningxin Gao, Liqiang Zhan, Shujiao He, Yifan Zhu, Yuexin Li, Björn Nashan, Schlegel Andrea, Jin Xu, Qiang Zhao, Xiaoshun He
Publikováno v:
EMBO Molecular Medicine, Vol 16, Iss 10, Pp 2322-2348 (2024)
Abstract Brain injury is the leading cause of mortality among patients who survive cardiac arrest (CA). Clinical studies have shown that the presence of post-CA hypoxic hepatitis or pre-CA liver disease is associated with increased mortality and infe
Externí odkaz:
https://doaj.org/article/b8a22a677ef1425390e3fb9f913d31a0
Autor:
Yunhua Tang, MD, Jiahao Li, MA, Tielong Wang, MD, Zhiheng Zhang, MD, Shanzhou Huang, MD, Zebin Zhu, MD, Linhe Wang, MD, Qiang Zhao, MD, Zhiyong Guo, MD, Xiaoshun He, MD
Publikováno v:
Transplantation Direct, Vol 10, Iss 5, p e1597 (2024)
Background. In organ transplantation, ischemia, and reperfusion injury (IRI) is considered as an inevitable event and the major contributor to graft failure. Ischemia-free liver transplantation (IFLT) is a novel transplant procedure that can prevent
Externí odkaz:
https://doaj.org/article/0cacc7d75899461a9962bd44be37d50b
Autor:
Linhe Wang, Jie Li, Shuai He, Yang Liu, Haitian Chen, Shujiao He, Meixian Yin, Dawei Zou, Shirui Chen, Tao Luo, Xinyu Yu, Xuesi Wan, Shunwei Huang, Zhiyong Guo, Xiaoshun He
Publikováno v:
Cell Death and Disease, Vol 12, Iss 6, Pp 1-17 (2021)
Abstract Ischemia–reperfusion injury (IRI) remains the major reason for impaired donor graft function and increased mortality post-liver transplantation. The mechanism of IRI involves multiple pathophysiological processes and numerous types of cell
Externí odkaz:
https://doaj.org/article/86ba605e8dd14dd6a0969bc23f2cdb3f
Autor:
Zhiyong Guo, Jinghong Xu, Shanzhou Huang, Meixian Yin, Qiang Zhao, Weiqiang Ju, Dongping Wang, Ningxin Gao, Changjun Huang, Lu Yang, Maogen Chen, Zhiheng Zhang, Zebin Zhu, Linhe Wang, Caihui Zhu, Yixi Zhang, Yunhua Tang, Haitian Chen, Kunpeng Liu, Yuting Lu, Yi Ma, Anbin Hu, Yinghua Chen, Xiaofeng Zhu, Xiaoshun He
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 4, Pp n/a-n/a (2022)
Abstract Background Ischemia‐reperfusion injury (IRI) is considered an inherent component of organ transplantation that compromises transplant outcomes and organ availability. The ischemia‐free liver transplantation (IFLT) procedure has been deve
Externí odkaz:
https://doaj.org/article/92d9da7823054f589bb9f70d3e9ea0a4
Autor:
Zhiyong Guo, M.D., Ph.D., Qiang Zhao, M.D., Ph.D., Shanzhou Huang, M.D., Ph.D., Changjun Huang, M.D., Dongping Wang, M.D., Ph.D., Lu Yang, M.D., Ph.D., Jian Zhang, M.Sc., Maogen Chen, M.D., Ph.D., Linwei Wu, M.D., Ph.D., Zhiheng Zhang, M.D., Zebin Zhu, M.D., Ph.D., Linhe Wang, M.D., Caihui Zhu, M.D., Yixi Zhang, M.D., Ph.D., Yunhua Tang, M.D., Ph.D., Chengjun Sun, M.D., Wei Xiong, M.D., Yuekun Shen, M.D., Ph.D., Xiaoxiang Chen, M.D., Jinghong Xu, M.D., Tielong Wang, M.D., Yi Ma, M.D., Ph.D., Anbin Hu, M.D., Ph.D., Yinghua Chen, M.D., Ph.D., Xiaofeng Zhu, M.D., Ph.D., Jian Rong, M.D., Ph.D., Changjie Cai, M.D., Ph.D., Fengqiu Gong, M.P.H., Xiangdong Guan, M.D., Ph.D., Wenqi Huang, M.D., Ph.D., Dicken Shiu-Chung Ko, M.D., Ph.D., Xianchang Li, M.D., Ph.D., Stefan G Tullius, M.D., Ph.D., Jiefu Huang, M.D., Ph.D., Weiqiang Ju, M.D., Ph.D., Xiaoshun He, M.D., Ph.D.
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 16, Iss , Pp 100260- (2021)
Summary: Background Ischaemia-reperfusion injury is considered an inevitable component of organ transplantation, compromising organ quality and outcomes. Although several treatments have been proposed, none has avoided graft ischaemia and its detrime
Externí odkaz:
https://doaj.org/article/0d55f75fdf2c4f79ae6d5716985bf8c4
Autor:
Yixi Zhang, Zebin Zhu, Shanzhou Huang, Qiang Zhao, Changjun Huang, Yunhua Tang, Chengjun Sun, Zhiheng Zhang, Linhe Wang, Huadi Chen, Maogen Chen, Weiqiang Ju, Xiaoshun He
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background MicroRNAs (miRNAs) play a pivotal role in hepatocellular carcinoma (HCC) progression and have been confirmed to participate in the carcinogenesis and development of HCC. However, the relationship between miR-497-5p and HCC remains
Externí odkaz:
https://doaj.org/article/22ca9928a79242e6be148ff860fb2a52
Autor:
Zhiyong Guo, Liqiang Zhan, Ningxin Gao, Zhiheng Zhang, Shanzhou Huang, Linhe Wang, Caihui Zhu, Zehua Jia, Meixian Yin, Fangcong Li, Shirui Chen, Tao Luo, Yao Liu, Yu Jia, Tielong Wang, Jinghong Xu, Yuexin Li, Yifan Zhu, Yichao Chen, Chuhan Yu, Yunhua Tang, Qiang Zhao, Dongping Wang, Xiaoshun He
Publikováno v:
Transplantation. 107:e139-e151
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f45f7a44d143ac5b70527723a44ab422
https://doi.org/10.1097/tp.0000000000004529
https://doi.org/10.1097/tp.0000000000004529
Autor:
Xiaoshun He, Guodong Chen, Zebin Zhu, Zhiheng Zhang, Xiaopeng Yuan, Ming Han, Qiang Zhao, Yitao Zheng, Yunhua Tang, Shanzhou Huang, Linhe Wang, Otto B. van Leeuwen, Xiaoping Wang, Chuanbao Chen, Liqiu Mo, Xingyuan Jiao, Xianchang Li, Changxi Wang, Jiefu Huang, Jun Cui, Zhiyong Guo
Publikováno v:
Frontiers in Medicine, Vol 6 (2019)
Background: Ischemia-reperfusion injury (IRI) has been considered an inevitable event in organ transplantation since the first successful kidney transplant was performed in 1954. To avoid IRI, we have established a novel procedure called ischemia-fre
Externí odkaz:
https://doaj.org/article/d75b802f802b49858b78460daf3ac1ef